Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Other financing activities (2017 - 2025)

Sensus Healthcare has reported Other financing activities over the past 9 years, most recently at $76000.0 for Q4 2025.

  • Quarterly results put Other financing activities at $76000.0 for Q4 2025, down 37.7% from a year ago — trailing twelve months through Dec 2025 was $300000.0 (down 7.69% YoY), and the annual figure for FY2025 was $300000.0, down 7.69%.
  • Other financing activities for Q4 2025 was $76000.0 at Sensus Healthcare, up from $73000.0 in the prior quarter.
  • Over the last five years, Other financing activities for SRTS hit a ceiling of $206000.0 in Q3 2021 and a floor of -$57000.0 in Q3 2022.
  • Median Other financing activities over the past 5 years was $69500.0 (2023), compared with a mean of $79800.0.
  • Biggest five-year swings in Other financing activities: soared 456.76% in 2021 and later crashed 127.67% in 2022.
  • Sensus Healthcare's Other financing activities stood at $90000.0 in 2021, then surged by 74.44% to $157000.0 in 2022, then tumbled by 59.24% to $64000.0 in 2023, then skyrocketed by 90.62% to $122000.0 in 2024, then tumbled by 37.7% to $76000.0 in 2025.
  • The last three reported values for Other financing activities were $76000.0 (Q4 2025), $73000.0 (Q3 2025), and $72000.0 (Q2 2025) per Business Quant data.